206 related articles for article (PubMed ID: 29785022)
21. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
[TBL] [Abstract][Full Text] [Related]
22. Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.
Hernandez-Fernaud JR; Ruengeler E; Casazza A; Neilson LJ; Pulleine E; Santi A; Ismail S; Lilla S; Dhayade S; MacPherson IR; McNeish I; Ennis D; Ali H; Kugeratski FG; Al Khamici H; van den Biggelaar M; van den Berghe PV; Cloix C; McDonald L; Millan D; Hoyle A; Kuchnio A; Carmeliet P; Valenzuela SM; Blyth K; Yin H; Mazzone M; Norman JC; Zanivan S
Nat Commun; 2017 Feb; 8():14206. PubMed ID: 28198360
[TBL] [Abstract][Full Text] [Related]
23. Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
Lu Y; Xu Q; Zuo Y; Liu L; Liu S; Chen L; Wang K; Lei Y; Zhao X; Li Y
BMC Cancer; 2017 Dec; 17(1):875. PubMed ID: 29262812
[TBL] [Abstract][Full Text] [Related]
24. Zerumbone inhibits tumor angiogenesis via NF-κB in gastric cancer.
Tsuboi K; Matsuo Y; Shamoto T; Shibata T; Koide S; Morimoto M; Guha S; Sung B; Aggarwal BB; Takahashi H; Takeyama H
Oncol Rep; 2014 Jan; 31(1):57-64. PubMed ID: 24220661
[TBL] [Abstract][Full Text] [Related]
25. Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.
Jeon HY; Lee YJ; Kim YS; Kim SY; Han ET; Park WS; Hong SH; Kim YM; Ha KS
FASEB J; 2019 Jan; 33(1):750-762. PubMed ID: 30020832
[TBL] [Abstract][Full Text] [Related]
26. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
[TBL] [Abstract][Full Text] [Related]
27. Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.
Malkomes P; Lunger I; Oppermann E; Lorenz J; Faqar-Uz-Zaman SF; Han J; Bothur S; Ziegler P; Bankov K; Wild P; Bechstein WO; Rieger MA
Cancer Gene Ther; 2023 Oct; 30(10):1346-1354. PubMed ID: 37443286
[TBL] [Abstract][Full Text] [Related]
28. Pterostilbene carboxaldehyde thiosemicarbazone, a resveratrol derivative inhibits 17β-Estradiol induced cell migration and proliferation in HUVECs.
Nikhil K; Sharan S; Wishard R; Palla SR; Krishna Peddinti R; Roy P
Steroids; 2016 Apr; 108():17-30. PubMed ID: 26850466
[TBL] [Abstract][Full Text] [Related]
29. The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity.
Zhao R; Sun L; Lin S; Bai X; Yu B; Yuan S; Zhang L
Oncol Rep; 2013 Apr; 29(4):1379-86. PubMed ID: 23404207
[TBL] [Abstract][Full Text] [Related]
30. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors.
Eligini S; Fiorelli S; Tremoli E; Colli S
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):922-30. PubMed ID: 27378395
[TBL] [Abstract][Full Text] [Related]
32. Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress.
Matlung HL; Neele AE; Groen HC; van Gaalen K; Tuna BG; van Weert A; de Vos J; Wentzel JJ; Hoogenboezem M; van Buul JD; VanBavel E; Bakker EN
Atherosclerosis; 2012 Oct; 224(2):355-62. PubMed ID: 22921425
[TBL] [Abstract][Full Text] [Related]
33. Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Kim SL; Park YR; Lee ST; Kim SW
Int J Oncol; 2017 Dec; 51(6):1809-1820. PubMed ID: 29075793
[TBL] [Abstract][Full Text] [Related]
34. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
35. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
[TBL] [Abstract][Full Text] [Related]
36. Monocytic Tissue Transglutaminase in a Rat Model for Reversible Acute Rejection and Chronic Renal Allograft Injury.
Zakrzewicz A; Atanasova S; Padberg W; Grau V
Mediators Inflamm; 2015; 2015():429653. PubMed ID: 26063971
[TBL] [Abstract][Full Text] [Related]
37. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.
Li T; Liu X; Shen Q; Yang W; Huo Z; Liu Q; Jiao H; Chen J
Oncotarget; 2016 May; 7(18):26580-92. PubMed ID: 27058891
[TBL] [Abstract][Full Text] [Related]
38. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
39. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
40. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
